Li David G, Cohen Jeffrey M, Mikailov Anar, Williams Ramone F, Laga Alvaro C, Mostaghimi Arash
Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Tufts University School of Medicine, Boston, MA, USA.
Dermatol Res Pract. 2018 Jul 3;2018:2630176. doi: 10.1155/2018/2630176. eCollection 2018.
Although onychomycosis can be diagnosed clinically, many guidelines still recommend pathologic confirmation of the diagnosis prior to initiation of systemic treatment. We retrospectively reviewed results from 541 toenail clippings (160 by dermatologists, 198 by podiatrists, and 183 by other provider types) sent to the Brigham and Women's Department of Dermatopathology between January 2000 and December 2013 for confirmatory periodic acid-Schiff (PAS) testing of clinically diagnosed onychomycosis. Of these, 93 (58.1%), 125 (63.1%), and 71 (38.8%) were sent for confirmation of onychomycosis (as opposed to diagnosis of onychodystrophy) by dermatologists, podiatrists, and other provider types, respectively. Confirmatory PAS stains were positive in 70 (75.3%), 101 (80.8%), and 47 (66.2%) of samples ordered by dermatologists, podiatrists, and other providers, respectively. Our study demonstrates that clinical diagnosis of onychomycosis in the appropriate clinical setting is accurate across specialties. Further prospective investigation on the accuracy of clinical diagnosis of onychomycosis may be beneficial.
虽然甲真菌病可通过临床诊断,但许多指南仍建议在开始全身治疗前进行病理诊断确认。我们回顾性分析了2000年1月至2013年12月期间送往布莱根妇女医院皮肤病理科的541份趾甲剪片(皮肤科医生送检160份,足病医生送检198份,其他科室医生送检183份)的结果,这些剪片用于对临床诊断的甲真菌病进行确证性高碘酸-希夫(PAS)检测。其中,皮肤科医生、足病医生和其他科室医生分别送检93份(58.1%)、125份(63.1%)和71份(38.8%)用于甲真菌病的确诊(而非甲营养不良的诊断)。皮肤科医生、足病医生和其他科室医生送检样本的PAS确证染色阳性率分别为70份(75.3%)、101份(80.8%)和47份(66.2%)。我们的研究表明,在适当的临床环境中,各专业对甲真菌病的临床诊断都是准确的。进一步对甲真菌病临床诊断准确性进行前瞻性研究可能是有益的。